Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Aptose Biosciences Inc (APS.TO)
Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 29,304
  • Shares Outstanding, K 7,326
  • Annual Sales, $ 0 K
  • Annual Income, $ -41,823 K
  • 60-Month Beta 2.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.58
Trade APS.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -7.63
  • Most Recent Earnings -2.27 on 08/10/23
  • Next Earnings Date 11/07/23
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -2.89
  • Number of Estimates 3
  • High Estimate -2.83
  • Low Estimate -2.96
  • Prior Year -2.10
  • Growth Rate Est. (year over year) -37.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.78 +0.26%
on 09/28/23
6.11 -37.97%
on 09/05/23
-1.81 (-32.32%)
since 08/28/23
3-Month
3.77 +0.53%
on 07/31/23
6.90 -45.07%
on 08/16/23
-2.23 (-37.04%)
since 06/28/23
52-Week
3.77 +0.53%
on 07/31/23
16.20 -76.60%
on 11/08/22
-8.21 (-68.42%)
since 09/28/22

Most Recent Stories

More News
Stocks in play: Aptose Biosciences Inc.

Announced that the Aptose management team will participate in the H.C. Wainwright 25th Annual Global ...

APS.TO : 3.79 (-5.25%)
Aptose Biosciences: Q2 Earnings Snapshot

Aptose Biosciences: Q2 Earnings Snapshot

APS.TO : 3.79 (-5.25%)
Stocks in play: Aptose Biosciences Inc.

Announced today that the company management team will provide a clinical update on Saturday, June 10, ...

APS.TO : 3.79 (-5.25%)
Aptose Biosciences: Q1 Earnings Snapshot

Aptose Biosciences: Q1 Earnings Snapshot

APS.TO : 3.79 (-5.25%)
Stocks in play: Aptose Biosciences Inc

Announced it has entered into an equity distribution agreement with JonesTrading Institutional Services ...

APS.TO : 3.79 (-5.25%)
Stocks in play: Aptose Biosciences Inc.

Has entered into an equity distribution agreement with JonesTrading Institutional Services LLC, as agent. ...

APS.TO : 3.79 (-5.25%)
Aptose Biosciences: Q3 Earnings Snapshot

Aptose Biosciences: Q3 Earnings Snapshot

APS.TO : 3.79 (-5.25%)
Aptose Reports Results for the Second Quarter 2022

─ HM43239 Preliminary Response Rate of 43% Among R/R AML Patients with FLT3 Mutations Who Failed Prior Therapy with FLT3 inhibitors ─ ─ HM43239 Complete...

APTO : 2.86 (-2.39%)
APS.TO : 3.79 (-5.25%)
Aptose to Present at the Canaccord Genuity 42nd Annual Growth Conference

SAN DIEGO and TORONTO, July 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

APTO : 2.86 (-2.39%)
APS.TO : 3.79 (-5.25%)
Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022

SAN DIEGO and TORONTO, July 19, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company...

APTO : 2.86 (-2.39%)
APS.TO : 3.79 (-5.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 4.02
2nd Resistance Point 4.01
1st Resistance Point 4.01
Last Price 3.79
1st Support Level 4.00
2nd Support Level 3.99
3rd Support Level 3.99

See More

52-Week High 16.20
Fibonacci 61.8% 11.45
Fibonacci 50% 9.99
Fibonacci 38.2% 8.52
Last Price 3.79
52-Week Low 3.77

See More

Business Summary

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar